Quick Answer
Akari Therapeutics Plc reported Shares Outstanding of 90.54 billion shares for fiscal year 2025.
Akari Therapeutics Plc Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 90.54B | +70.2% |
| 2024 | 53.19B | +301.9% |
| 2023 | 13.23B | +77.8% |
| 2022 | 7.44B | +56.4% |
| 2021 | 4.76B | +23.7% |
| 2020 | 3.85B | +71.3% |
| 2019 | 2.25B | +719685.0% |
| 2018 | 312,019 | -100.0% |
| 2017 | 1.53B | +29.5% |
| 2016 | 1.18B | +0.0% |
| 2015 | 1.18B | +63.0% |
| 2014 | 722.35M | +1695.6% |
| 2013 | 40.23M | +200.9% |
| 2012 | 13.37M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 65.23B | +168.6% | +0.0% |
| June 30, 2025 | 65.23B | +168.6% | +12.9% |
| March 31, 2025 | 57.75B | +261.6% | +8.6% |
| December 31, 2024 | 53.19B | +301.9% | +119.0% |
| September 30, 2024 | 24.29B | — | -0.0% |
| June 30, 2024 | 24.29B | — | +52.1% |
| March 31, 2024 | 15.97B | — | +20.7% |
| December 31, 2023 | 13.23B | — | +1023.7% |
- Akari Therapeutics Plc showed an increase of +70.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2012–2025 period, Akari Therapeutics Plc’s shares outstanding has grown by 677074.1% (from 13.37 million shares to 90.54 billion shares).
- The most recent figure is from Akari Therapeutics Plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: